Select to order medicines [Delhi/NCR /Bangalore /Chennai /Bhubaneswar /Mumbai]
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
There are no controlled studies in breastfeeding women, however the risk of untoward effects to a breastfed infant is possible; or, controlled studies show only minimal non-threatening adverse effects. Drugs should be given only if the potential benefit justifies the potential risk to the infant.
Typical usage: Angina, cardiac arrhythmia, hypertension, hyperthyroidism (adjunct), maintenance of recurrent duodenal ulcers, migraine prophylaxis, myocardial infarction, prevention of relapse in duodenal ulcer.
Side Effects: Agranulocytosis, hyperglycemia, severe bradycardia, bradycardia, dizziness, fatigue, nausea, vomiting, alopecia, diarrhea, dyspnea, pruritus, GI upset, elevation of liver enzymes, hyperpigmentation, sleep pattern disturbances.
Drug Interaction: Metoprolol (Tartrate) is known to interact with other drugs like alprazolam, amiodarone (HCl), aspirin, benorylate, choline magnesium trisalicylate, cimetidine (HCl), clonidine (HCl), clorazepate (K), dexamphetamine (Sulphate), diltiazem (HCl), fluoxetine (HCl), fluvoxamine (Maleate). Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Mechanism Of Action: Metoprolol competes with adrenergic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors in the heart. Beta(1)-receptor blockade results in a decrease in heart rate, cardiac output, and blood pressure.
Showing 5 of 89
Showing 5 of 89